Koppel Adam
Insider CIK 1578965 · PTCT Director · MRNS 10% owner · RPID 10% owner · DRNA Director, 10% owner · TRVN Director · ANNX 10% owner · APTX Director, 10% owner · SLDB Director, 10% owner · REPL Director · SWTX 10% owner · ARQT 10% owner · CERE Director, 10% owner · FHTX Director · BLSA Director, 10% owner · KLRA Director, 10% owner · BIIB SVP, Chief Strategy Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics, Inc. | C Conversion deriv | 2026-04-20 | 2026-04-20 | 16,875,000 | — | $0 | 0 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | C Conversion deriv | 2026-04-20 | 2026-04-20 | 4,145,768 | — | $0 | 0 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | C Conversion | 2026-04-20 | 2026-04-20 | 16,875,000 | — | $0 | 16,875,000 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | P Buy | 2026-04-20 | 2026-04-20 | 1,562,500 | $16.00 | $25.00M | 22,583,268 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | C Conversion | 2026-04-20 | 2026-04-20 | 4,145,768 | — | $0 | 21,020,768 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 38,300 | — | $0 | 38,300 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 80,189 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 3,282 | — | $0 | 10,461 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 10,461 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 65,679,781 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 16,000 | $5.52 | $88.3K | 16,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2024-06-05 | 2024-06-07 | 10,461 | — | $0 | 13,743 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2024-01-11 | 2024-01-12 | 904,160 | $5.53 | $5.00M | 4,034,582 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2023-10-16 | 2023-10-18 | 5,480,052 | $22.81 | $125.00M | 65,679,781 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-06-21 | 2023-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-07 | 2023-06-09 | 13,780 | — | $0 | 13,780 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | J Other | 2023-06-07 | 2023-06-09 | 432,627 | — | $0 | 60,199,729 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2023-06-07 | 2023-06-09 | 3,282 | — | $0 | 3,282 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-13 | 2022-12-15 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-02 | 2022-12-05 | 2,666 | — | $0 | 2,666 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-06-14 | 2022-06-16 | 23,459 | — | $0 | 23,459 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | U Tender | 2021-12-28 | 2021-12-29 | 3,080,237 | $38.25 | $117.82M | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-08-10 | 2021-08-12 | 1,000,000 | $70.25 | $70.25M | 4,831,307 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-21 | 35,000,001 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-21 | 6,672,819 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion | 2021-07-19 | 2021-07-21 | 6,999,998 | — | $0 | 6,999,998 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | P Buy | 2021-07-19 | 2021-07-21 | 100,000 | $20.00 | $2.00M | 8,434,560 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion | 2021-07-19 | 2021-07-21 | 1,334,562 | — | $0 | 8,334,560 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-07-13 | 2021-07-14 | 12,530 | — | $0 | 12,530 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-06-10 | 2021-06-14 | 42,950 | — | $0 | 42,950 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2021-05-27 | 2021-06-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2021-03-23 | 2021-03-25 | 869,565 | $5.75 | $5.00M | 7,929,918 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-03-09 | 2021-03-11 | 1,450,000 | $71.50 | $103.67M | 5,831,307 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-12-31 | 2021-01-05 | 5,508 | $2.22 | $12.2K | 5,508 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2020-12-10 | 2020-12-11 | 3,189,189 | $3.70 | $11.80M | 7,060,353 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2020-12-10 | 2020-12-14 | 1,000,000 | $23.40 | $23.40M | 3,080,237 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2020-11-09 | 2020-11-12 | 332,293 | $10.30 | $3.42M | 60,632,356 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2020-10-27 | 2020-10-29 | 10,000,000 | $10.00 | $100.00M | 60,300,063 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | J Other | 2020-10-27 | 2020-10-29 | 49,961,943 | — | $0 | 50,300,063 | SEC↗ |
| BLSA BCLS Acquisition Corp. | A Award | 2020-10-26 | 2020-10-26 | 487,500 | $10.00 | $4.88M | 487,500 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2020-10-26 | 2020-10-27 | 3,333,333 | $3.00 | $10.00M | 8,891,758 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-09-30 | 2020-10-02 | 5,663 | $2.16 | $12.2K | 5,663 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 22,222,221 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 2,812,543 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 400,000 | $17.00 | $6.80M | 3,241,628 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 319,243 | — | $0 | 2,841,628 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 2,522,385 | — | $0 | 2,522,385 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-06-30 | 2020-07-02 | 4,370 | $2.68 | $11.7K | 4,370 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 3,333 | — | $0 | 3,333 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-05-20 | 2020-05-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-03-31 | 2020-04-02 | 8,296 | $1.36 | $11.3K | 8,296 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 2,825,602 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 859,573 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 2,825,602 | — | $0 | 2,825,602 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-04 | 2020-02-06 | 294,117 | $17.00 | $5.00M | 3,979,292 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 859,573 | — | $0 | 3,685,175 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2020-01-14 | 2020-01-16 | 3,333,333 | $3.00 | $10.00M | 5,558,425 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-12-04 | 2019-12-06 | 1,500,000 | $24.68 | $37.02M | 4,080,237 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-11-19 | 2019-11-21 | 1,750,000 | $22.03 | $38.55M | 5,580,237 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | P Buy | 2019-09-17 | 2019-09-19 | 150,000 | $18.00 | $2.70M | 7,281,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 6,078,103 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 7,131,307 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2019-07-30 | 2019-07-30 | 1,881,720 | $4.65 | $8.75M | 3,871,164 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-06-20 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-05-29 | 2019-05-31 | 1,600,000 | $12.50 | $20.00M | 7,330,237 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-05-15 | 2019-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2018-12-13 | 2018-12-17 | 8,165 | — | $0 | 8,165 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2018-07-25 | 2018-07-27 | 1,835 | — | $0 | 1,835 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-26 | 235,146 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | P Buy | 2018-07-24 | 2018-07-26 | 500,000 | $15.00 | $7.50M | 2,838,968 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion | 2018-07-24 | 2018-07-26 | 2,338,968 | — | $0 | 2,338,968 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 50,347,397 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,825,092 | — | $0 | 1,825,092 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 400,000 | $16.00 | $6.40M | 2,225,092 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-05-16 | 2018-05-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | P Buy | 2018-01-30 | 2018-02-01 | 300,000 | $16.00 | $4.80M | 1,989,444 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2018-01-25 | 2018-02-01 | 1,991,097 | — | $0 | 0 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2018-01-25 | 2018-02-01 | 1,689,444 | — | $0 | 1,689,444 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-19 | 2017-12-19 | 94,771 | $7.62 | $722.2K | 4,032,682 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-19 | 2017-12-19 | 55,229 | $7.11 | $392.7K | 3,977,453 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2017-12-18 | 2017-12-19 | 250,000 | $3.19 | $797.5K | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2017-12-18 | 2017-12-19 | 285,000 | $7.00 | $2.00M | 285,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2017-12-18 | 2017-12-19 | 8,454,388 | — | $0 | 8,739,388 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award | 2017-12-18 | 2017-12-19 | 190,849 | — | $0 | 8,930,237 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-18 | 2017-12-19 | 300,000 | $7.50 | $2.25M | 4,127,453 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-15 | 2017-12-19 | 102,882 | $8.64 | $888.9K | 4,427,453 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-15 | 2017-12-19 | 719,665 | $8.02 | $5.77M | 4,530,335 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2017-10-26 | 2018-02-01 | 1,223,240 | — | $0 | 1,991,097 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2017-07-18 | 2017-07-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-05-17 | 2017-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2017-04-11 | 2017-04-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-06-06 | 2016-06-07 | 555 | $290.00 | $160.9K | 2,402 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-06-02 | 2016-06-06 | 1,969 | — | $0 | 3,616 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-06-02 | 2016-06-06 | 1,643 | — | $0 | 5,585 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-06-02 | 2016-06-06 | 1,643 | — | $0 | 3,491 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-06-02 | 2016-06-06 | 534 | $289.73 | $154.7K | 2,957 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2016-05-18 | 2016-05-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-04-06 | 2016-04-07 | 102 | $275.00 | $28.1K | 1,848 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-23 | 2016-02-25 | 301 | — | $0 | 2,399 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-23 | 2016-02-25 | 597 | — | $0 | 1,802 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-23 | 2016-02-25 | 98 | $258.99 | $25.4K | 1,865 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-23 | 2016-02-25 | 301 | — | $0 | 1,963 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2016-02-22 | 2016-02-24 | 7,270 | — | $0 | 7,270 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2015-06-02 | 2015-06-04 | 1,228 | — | $0 | 7,228 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2015-06-02 | 2015-06-04 | 2,384 | — | $0 | 8,456 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2015-06-02 | 2015-06-04 | 852 | $387.62 | $330.3K | 1,662 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2015-06-02 | 2015-06-04 | 2,384 | — | $0 | 2,514 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2015-05-20 | 2015-05-21 | 8,870 | — | $0 | 8,870 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 2,700 | — | $0 | 2,700 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2015-01-02 | 2015-01-02 | 12,000 | $51.00 | $612.0K | 12,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-09-17 | 2014-09-19 | 17,741 | — | $0 | 17,741 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-06-02 | 2014-06-03 | 10,840 | — | $0 | 10,840 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2014-01-28 | 2014-01-30 | 10,000 | $27.05 | $270.5K | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion deriv | 2013-06-25 | 2013-06-28 | 1,083,333 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy | 2013-06-25 | 2013-06-28 | 1,250,000 | $15.00 | $18.75M | 2,333,333 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion | 2013-06-25 | 2013-06-28 | 1,083,333 | — | $0 | 1,083,333 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2013-03-07 | 2013-06-28 | 1,083,333 | $12.00 | $13.00M | 1,083,333 | SEC↗ |